Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C511295 |
2,2,4,4-tetrabromodiphenyl ether |
2,2,4,4-tetrabromodiphenyl ether results in decreased expression of APOB mRNA | decreases expression | 16488489
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene results in decreased expression of APOB mRNA | decreases expression | 16917068
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of APOB mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of APOB mRNA | decreases expression | 20406850
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of APOB mRNA | affects expression | 21346803
|
C016392 |
3,3'-diindolylmethane |
3,3'-diindolylmethane results in decreased expression of APOB mRNA | decreases expression | 16192472
|
C471109 |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased secretion of APOB protein | decreases secretion | 19342510
|
C471109 |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline |
acetylleucyl-leucyl-norleucinal inhibits the reaction [4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased secretion of APOB protein] | decreases reaction|decreases secretion | 19342510
|
C471109 |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline inhibits the reaction [Fructose results in increased expression of APOB protein] | decreases reaction|increases expression | 19342510
|
C471109 |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased expression of APOB protein | decreases expression | 19342510
|
C041594 |
4-nonylphenol |
4-nonylphenol results in decreased expression of APOB mRNA | decreases expression | 17912697
|
C063261 |
acetylleucyl-leucyl-norleucinal |
acetylleucyl-leucyl-norleucinal inhibits the reaction [4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased secretion of APOB protein] | decreases reaction|decreases secretion | 19342510
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of APOB protein | affects expression | 20106945
|
D000535 |
Aluminum |
Aluminum results in increased expression of APOB protein | increases expression | 17762189
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of APOB mRNA | affects expression | 16483693
|
D001205 |
Ascorbic Acid |
Ascorbic Acid promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D001205 |
Ascorbic Acid |
Ascorbic Acid promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D001205 |
Ascorbic Acid |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of APOB mRNA | affects cotreatment|decreases expression | 17639512
|
C065179 |
atorvastatin |
atorvastatin results in decreased expression of and results in decreased secretion of APOB protein | decreases expression|decreases secretion | 12612140
|
C065179 |
atorvastatin |
atorvastatin inhibits the reaction [Fructose results in increased expression of APOB protein] | decreases reaction|increases expression | 12065722
|
D001554 |
Benzene |
Benzene results in increased expression of APOB mRNA | increases expression | 15878777
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of APOB mRNA | decreases expression | 20106945
|
C095105 |
bexarotene |
bexarotene results in decreased expression of APOB mRNA | decreases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of APOB mRNA | decreases expression | 17912697
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of APOB mRNA | increases expression | 17010207
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of APOB protein | decreases expression | 17405876
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of APOB mRNA | affects expression | 15963342
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of APOB mRNA | decreases expression | 19224547 16644059
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of APOB mRNA | increases expression | 18178546
|
D002784 |
Cholesterol |
Cholesterol results in increased expression of APOB protein | increases expression | 16581047 16271152
|
D002784 |
Cholesterol |
Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] | decreases reaction|increases expression | 16581047
|
D003300 |
Copper |
Ascorbic Acid promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D003300 |
Copper |
Ascorbic Acid promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D003300 |
Copper |
Copper results in increased oxidation of APOB protein | increases oxidation | 17475462
|
D003300 |
Copper |
Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein] | decreases reaction|increases oxidation | 17475462
|
D003300 |
Copper |
Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein] | decreases reaction|increases oxidation | 17475462
|
D003300 |
Copper |
Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D003300 |
Copper |
Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of APOB mRNA | decreases expression | 18246545
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of APOB mRNA | decreases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of APOB mRNA | decreases expression | 19224547
|
C017160 |
cypermethrin |
cypermethrin results in increased expression of APOB mRNA | increases expression | 9650644
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of APOB protein | increases expression | 15965953
|
D004281 |
Docosahexaenoic Acids |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein | affects cotreatment|decreases expression | 17237316
|
D015118 |
Eicosapentaenoic Acid |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein | affects cotreatment|decreases expression | 17237316
|
D004958 |
Estradiol |
Estradiol results in decreased expression of APOB mRNA | decreases expression | 17912697
|
D004958 |
Estradiol |
Estradiol results in increased stability of APOB protein | increases stability | 11076531
|
D004958 |
Estradiol |
Estradiol results in decreased expression of APOB mRNA | decreases expression | 16192472
|
D000431 |
Ethanol |
Ethanol results in increased expression of APOB mRNA | increases expression | 16946407
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of APOB mRNA | decreases expression | 17912697
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein | affects cotreatment|increases expression | 15769986
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOB mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of APOB mRNA | decreases expression | 16488489
|
D005419 |
Flavonoids |
Ascorbic Acid promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D005419 |
Flavonoids |
Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein] | decreases reaction|increases oxidation | 17475462
|
D005419 |
Flavonoids |
Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D005492 |
Folic Acid |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein | affects cotreatment|decreases expression | 17237316
|
D005492 |
Folic Acid |
Folic Acid results in increased expression of APOB mRNA | increases expression | 17868486
|
D005632 |
Fructose |
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline inhibits the reaction [Fructose results in increased expression of APOB protein] | decreases reaction|increases expression | 19342510
|
D005632 |
Fructose |
Fructose results in increased expression of APOB protein | increases expression | 19342510
|
D005632 |
Fructose |
atorvastatin inhibits the reaction [Fructose results in increased expression of APOB protein] | decreases reaction|increases expression | 12065722
|
D005632 |
Fructose |
Fructose results in increased expression of APOB mRNA | increases expression | 8415773
|
D005632 |
Fructose |
Fructose results in increased expression of APOB protein | increases expression | 8415773 12065722
|
D005707 |
Gallic Acid |
Gallic Acid results in decreased secretion of APOB protein | decreases secretion | 12612140
|
D019833 |
Genistein |
Genistein results in increased expression of APOB mRNA | increases expression | 17010207
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in decreased expression of APOB mRNA | decreases expression | 16192472
|
C081309 |
irbesartan |
APOB gene SNP affects the susceptibility to irbesartan | affects response to substance | 15453913 15614026
|
C051140 |
iron(II)-ascorbic acid complex |
iron(II)-ascorbic acid complex results in decreased expression of APOB protein | decreases expression | 10898742
|
D001556 |
Lindane |
Lindane affects the expression of APOB mRNA | affects expression | 17785943
|
C003297 |
nandrolone decanoate |
nandrolone decanoate results in increased expression of APOB protein | increases expression | 16153628
|
C025256 |
nonylphenol |
nonylphenol results in increased expression of APOB mRNA | increases expression | 17010207
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein | affects cotreatment|increases expression | 15769986
|
C025589 |
ochratoxin A |
ochratoxin A results in decreased expression of APOB mRNA | decreases expression | 16251485
|
D019301 |
Oleic Acid |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein | affects cotreatment|decreases expression | 17237316
|
C005958 |
palmidrol |
palmidrol affects the folding of APOB protein | affects folding | 16115474
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of APOB mRNA | increases expression | 17560707
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid affects the localization of APOB protein | affects localization | 10101272
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of APOB protein | decreases expression | 15537571
|
C006253 |
pirinixic acid |
pirinixic acid results in increased secretion of APOB protein | increases secretion | 16282640
|
C006253 |
pirinixic acid |
pirinixic acid results in increased secretion of APOB protein alternative form | increases secretion | 15537571
|
C025299 |
polyphenols |
polyphenols results in decreased expression of APOB protein | decreases expression | 16046716
|
C025299 |
polyphenols |
polyphenols results in decreased expression of APOB mRNA | decreases expression | 16293270
|
D011341 |
Probucol |
Probucol results in decreased expression of APOB mRNA | decreases expression | 16292755
|
D011794 |
Quercetin |
Ascorbic Acid promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D011794 |
Quercetin |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of APOB mRNA | affects cotreatment|decreases expression | 17639512
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein] | decreases reaction|increases oxidation | 17475462
|
D011794 |
Quercetin |
Quercetin results in decreased secretion of APOB protein | decreases secretion | 12612140
|
D011794 |
Quercetin |
Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
C059514 |
resveratrol |
resveratrol results in decreased secretion of APOB protein | decreases secretion | 12612140
|
D012643 |
Selenium |
Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] | decreases reaction|increases expression | 16581047
|
D012643 |
Selenium |
Selenium results in decreased expression of APOB protein | decreases expression | 16271152
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of APOB mRNA | decreases expression | 16882884
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of APOB mRNA | affects expression | 19590694
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of APOB mRNA | decreases expression | 19224547
|
C003377 |
taxifolin |
taxifolin results in decreased expression of APOB protein | decreases expression | 11108730
|
C003377 |
taxifolin |
taxifolin results in decreased secretion of APOB protein | decreases secretion | 15380446
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOB mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of APOB mRNA | decreases expression | 15703262
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APOB mRNA | increases expression | 16267337
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APOB mRNA | increases expression | 15644576 11752688
|
D013752 |
Tetracycline |
Tetracycline results in decreased expression of APOB mRNA | decreases expression | 19224547
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in decreased expression of APOB mRNA | decreases expression | 17982090
|
D025101 |
Vitamin B 6 |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein | affects cotreatment|decreases expression | 17237316
|
D014810 |
Vitamin E |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein | affects cotreatment|decreases expression | 17237316
|
D014810 |
Vitamin E |
Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
D014810 |
Vitamin E |
Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] | decreases reaction|increases oxidation|increases reaction | 17475462
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.92 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
6.44 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.44 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.42 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.42 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.31 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
7.19 | 16595132 16316344 17003819 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.19 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.55 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
8.47 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
8.47 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
8.47 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
8.47 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
9.07 | 6695378 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
9.07 | 16963246 |
MESH:D000236 |
Adenoma |
|
resveratrol |
9.07 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
7.86 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
7.86 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.07 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.27 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
cypermethrin |
7.37 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
7.37 | 12661182 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.69 | 15451040 15451039 |
MESH:D000544 |
Alzheimer Disease |
|
Aluminum |
8.04 | 10721010 17662457 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
8.04 | 17119284 16962711 16886094 16325427 16866297 16410023 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
8.04 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
8.04 | 16183991 16162502 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
3.89 | 10694572 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.41 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.88 | 11369114 17661222 14761424 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.68 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
4.34 | 16614410 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.22 | 15513904 |
MESH:D000860 |
Anoxia |
|
Oleic Acid |
5.28 | 15090967 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.51 | 11141031 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.47 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
8.17 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.17 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
9.96 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
9.96 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
9.96 | 17115116 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.36 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
5.94 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.94 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
2.63 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.63 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
Vitamin B 6 |
2.63 | 16846101 16494569 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.81 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
6.93 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
6.93 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.16 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.34 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.60 | 16183116 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.31 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.67 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
4.02 | 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
15.86 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
15.86 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
15.86 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
15.86 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
15.86 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
15.86 | 17079463 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
15.86 | 17388661 15093573 18234424 18323546 15136595 12006526 17020986 11325840 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
15.86 | 12948864 17289903 18497071 14630087 16675129 17261762 17018787 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
15.86 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
15.86 | 17200150 16541309 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
indole-3-carbinol |
15.86 | 16082211 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
15.86 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
ochratoxin A |
15.86 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
15.86 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
15.86 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
15.86 | 15565566 20065188 19155303 20005174 19084267 18821012 18629630 19059307 20544844 17242785 19142967 18425577 11161223 19487384 19011961 16273361 15668708 18984771 20135344 18997820 19410462 18351453 19288272 19289846 17893378 19244106 21138602 17440819 19189212 16818667 20390343 17049068 19200415 18855134 19189210 19066611 20859285 16873071 21152245 16202921 18815881 19103187 17261762 19221464 19115204 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
15.86 | 20435547 |
MESH:D002056 |
Burns |
|
Ethanol |
4.05 | 16374292 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.92 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.85 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
7.94 | 3786805 16124888 16192424 16097048 16050911 18705752 10355542 16011737 15673190 15721981 16227642 15700767 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
7.94 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.31 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.90 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
25.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
25.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
25.70 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
25.70 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
25.70 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
25.70 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
25.70 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
25.70 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
25.70 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
25.70 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
25.70 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
25.70 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.37 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
9.44 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.44 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
2.98 | 16247446 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.35 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.21 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
6.24 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
6.24 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
6.24 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.08 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
atorvastatin |
17.51 | 18360054 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
17.51 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
17.51 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
17.51 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
17.51 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
9.73 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
9.73 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
9.73 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
12.36 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.36 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
12.36 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.36 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.64 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
15.44 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
15.44 | 15861022 11677210 17333356 16919318 17110522 16105132 17681005 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
15.44 | 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
15.44 | 19176532 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
6.69 | 15513904 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
6.69 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
8.21 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
8.21 | 21254359 8946559 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.21 | 15668235 8697196 15340226 16354765 12621046 |
MESH:D003092 |
Colitis |
|
resveratrol |
12.69 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
12.69 | 17936198 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
12.69 | 16867261 16782535 11698051 18200517 17991707 16474422 18023891 17936198 16804969 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.20 | 17276891 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
9.39 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
9.39 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
9.39 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
9.39 | 17191121 11134977 19056647 15741050 16640504 19440933 17148506 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
9.39 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
3.19 | 17087956 17245555 16963246 17116713 16985020 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.19 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.19 | 16550006 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
4.85 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.54 | 14669216 17141729 |
MESH:D003324 |
Coronary Artery Disease |
|
atorvastatin |
3.88 | 16368305 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
7.38 | 18504504 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
7.38 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
10.25 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
10.25 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
10.25 | 11873399 19302082 15451040 11198716 10194807 15451039 15513904 |
MESH:D019465 |
Craniofacial Abnormalities |
|
ochratoxin A |
10.25 | 20036863 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
10.25 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
10.25 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
10.25 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.89 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.89 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
4.14 | 19747007 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.36 | 15276878 18433785 16413132 17979934 10498854 16989017 15643279 16651033 18372110 17010015 16614059 18710439 12388444 18483878 11948286 12161096 18093676 18295254 10700343 12913760 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.76 | 19031437 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.16 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.85 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.11 | 18249437 |
MESH:D002658 |
Developmental Disabilities |
|
Vitamin B 6 |
5.24 | 16846101 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
15.72 | 10990075 15331540 11751995 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
15.72 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
15.72 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
15.72 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.00 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
11.53 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
11.53 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
11.53 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
11.53 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
11.53 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
11.99 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
11.99 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
11.99 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.13 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
24.55 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
24.55 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
24.55 | 3732212 7440962 6623471 10915739 16227642 4309450 16177239 21278145 7120509 17522070 15998439 9327722 19085960 15968718 3786805 11566570 2869522 15027814 10092053 19336974 7179309 6884620 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
24.55 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
24.55 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
24.55 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
24.55 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
24.55 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
24.55 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
24.55 | 17522070 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.29 | 11462148 |
MESH:D004417 |
Dyspnea |
|
cypermethrin |
4.76 | 16487989 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
10.98 | 9068938 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
10.98 | 9068938 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.87 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
15.86 | 19703484 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
15.86 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
15.86 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
15.86 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
15.86 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.27 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
11.98 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
11.98 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
11.98 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
3.97 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
14.31 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
14.31 | 17301261 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
14.31 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
14.31 | 19155303 17893378 16202921 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.49 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.25 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.62 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
3.93 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
3.93 | 16704527 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
4.87 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.54 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
33.64 | 17595544 19224547 16239168 16045604 12795759 61145 15959796 12631006 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
33.64 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
33.64 | 16409862 19236843 18620774 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
33.64 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
33.64 | 18395287 19196556 18641190 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
33.64 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
33.64 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
33.64 | 16917069 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.03 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.83 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.68 | 16946407 15451040 15513904 10194807 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.86 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.91 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.57 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
26.76 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
26.76 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Fructose |
26.76 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
26.76 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
26.76 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
26.76 | 17994277 |
MESH:D005756 |
Gastritis |
|
Ethanol |
9.56 | 15046732 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
9.56 | 17171786 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.06 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.60 | 8708960 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.51 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
5.94 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
5.94 | 19804834 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.78 | 17643826 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
4.90 | 11389073 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
9.96 | 19165636 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
9.96 | 19446573 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.96 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.43 | 16376943 15172196 11014644 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
17.23 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
17.23 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
17.23 | 16524890 17286298 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
17.23 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
17.23 | 16080930 |
MESH:D006333 |
Heart Failure |
|
atorvastatin |
9.59 | 16360360 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
9.59 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
9.59 | 17162251 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.08 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.80 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.69 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.78 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
4.90 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
7.89 | 19110552 19900420 |
MESH:D006505 |
Hepatitis |
|
cypermethrin |
7.89 | 16487989 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.65 | 17338147 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
4.57 | 17109627 17182432 17276780 16607473 19888908 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
11.00 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
11.00 | 19176532 18467677 16221962 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.00 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
8.17 | 16490937 16863852 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
8.17 | 7520565 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
8.17 | 16863852 16490937 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.40 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.57 | 16876885 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
4.87 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
5.90 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
5.90 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
7.97 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
7.97 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.42 | 18606429 16354765 15340226 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
6.59 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
6.59 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.91 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
marker/mechanism |
|
| |
MESH:D006937 |
Hypercholesterolemia |
|
atorvastatin |
12.49 | 11583720 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
12.49 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
12.49 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
7.45 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
7.45 | 18262572 11834736 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
8.57 | 16865747 16755160 16397167 16433478 16395265 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Vitamin B 6 |
8.57 | 16397167 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.38 | 14757778 19008412 18360027 15752949 18563319 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
7.82 | 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
7.82 | 16873680 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
marker/mechanism |
|
| |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
atorvastatin |
4.67 | 16238680 |
MESH:D006973 |
Hypertension |
|
atorvastatin |
24.58 | 17042910 |
MESH:D006973 |
Hypertension |
|
Benzene |
24.58 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
24.58 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
24.58 | 17042910 |
MESH:D006973 |
Hypertension |
|
Fructose |
24.58 | 16843071 19008412 14573337 14568997 14633139 |
MESH:D006973 |
Hypertension |
|
irbesartan |
24.58 | 11593098 15453913 12359989 12022239 14700505 15188945 11910301 13678427 18464745 15614026 |
MESH:D006973 |
Hypertension |
|
Quercetin |
24.58 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
24.58 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.49 | 15338365 |
MESH:D015228 |
Hypertriglyceridemia |
marker/mechanism |
|
| 20657596 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.54 | 19799862 19342510 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.76 | 17488730 |
MESH:D006995 |
Hypobetalipoproteinemias |
marker/mechanism |
|
| |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.21 | 16945680 16569931 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.70 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.04 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.89 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
8.77 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
8.77 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
8.77 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Aluminum |
26.07 | 16052892 |
MESH:D007249 |
Inflammation |
|
atorvastatin |
26.07 | 16908763 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
26.07 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
26.07 | 17296493 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
26.07 | 12083418 |
MESH:D007249 |
Inflammation |
|
polyphenols |
26.07 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
26.07 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
26.07 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
26.07 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.29 | 18200517 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
21.49 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
21.49 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
21.49 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
21.49 | 16624496 |
MESH:D007299 |
Insect Bites and Stings |
|
cypermethrin |
5.35 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
14.19 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
14.19 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
14.19 | 18563319 19799862 14633139 17133782 18981581 19342510 14573337 19008412 19586609 14757778 18057795 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
14.19 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
4.01 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.27 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.27 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.35 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.81 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
18.86 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
18.86 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
ochratoxin A |
18.86 | 11409539 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
18.86 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
18.86 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
18.86 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
8.41 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
8.41 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
22.54 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
22.54 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
22.54 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
22.54 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
ochratoxin A |
22.54 | 16251485 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
22.54 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
12.91 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Copper |
12.91 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
12.91 | 15451040 |
MESH:D007938 |
Leukemia |
|
Benzene |
12.19 | 14694614 17119257 18335105 15935818 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
12.19 | 10602166 |
MESH:D007938 |
Leukemia |
|
Genistein |
12.19 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
12.19 | 17468513 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.20 | 17802794 17296974 17008537 18587576 18172266 17658394 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
4.45 | 17077332 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.62 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
3.77 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.57 | 19478238 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.15 | 16087638 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.35 | 11830472 10052129 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.61 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.36 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.70 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.57 | 16943688 21278145 16221502 11903743 17174718 17157831 17334410 11408273 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
5.57 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.48 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
atorvastatin |
18.19 | 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
18.19 | 17640975 17805973 12445421 15996030 17900296 18210741 18420326 15123356 12667390 12586293 12609069 12741479 18395095 18412020 17525996 17714472 18187930 18339082 17976157 10355542 17766677 18279442 18418968 18376398 16011737 18251166 16192424 15818738 12632512 18205269 17631135 17761835 14716833 17708605 18263696 15362042 15959796 15338365 18156304 16248980 18429990 17721639 16027843 12445418 15052691 12389079 12958196 12546737 13678700 17565644 16033810 18395914 15876570 17481882 16097048 18472332 15057751 15650968 15931870 16638106 18705752 16015684 17698563 11481614 15893842 16116963 18054572 18317297 12666154 18277467 18472094 17823541 16136751 14620537 14512876 15673190 18006644 15925388 18481824 15370692 20821823 18166357 17944888 17922224 12649538 14716496 12632514 14724832 17869086 17557913 14748882 12898905 15730626 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
18.19 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
18.19 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
18.19 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
18.19 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
18.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
18.19 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
18.19 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
18.19 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
18.19 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
13.18 | 16246199 16964402 15720792 15830285 17285989 |
MESH:D008107 |
Liver Diseases |
|
cypermethrin |
13.18 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
13.18 | 17056761 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
13.18 | 16877991 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
13.18 | 1715830 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
13.18 | 16698588 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.05 | 17347304 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.56 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.15 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
35.91 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
35.91 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
35.91 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
35.91 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
35.91 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
35.91 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
35.91 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
35.91 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
35.91 | 19812893 19321006 19073162 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
35.91 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
35.91 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
35.91 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
26.05 | 2876786 6135515 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
26.05 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
26.05 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
26.05 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
26.05 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Probucol |
26.05 | 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
26.05 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
26.05 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Aluminum |
14.11 | 16052892 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
14.11 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
14.11 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
14.11 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.18 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Oleic Acid |
4.75 | 15090967 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
17.86 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
17.86 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
17.86 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
17.86 | 18520028 18816296 20464547 18569708 17053015 20064080 20135361 20869020 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
17.86 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
17.86 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
17.86 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
17.86 | 17306315 17077188 15276417 19931552 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
17.86 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
17.86 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
17.86 | 11062179 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
3.13 | 17718048 |
MESH:D008223 |
Lymphoma |
|
Benzene |
6.46 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
6.46 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
8.58 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.58 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
7.32 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.32 | 14749477 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.54 | 11161223 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
13.26 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
13.26 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
13.26 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
26.16 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
26.16 | 15591091 19196723 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
26.16 | 16891317 11408345 11807958 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
26.16 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
ochratoxin A |
26.16 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
26.16 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
26.16 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
26.16 | 19196722 14580682 16827153 11731420 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.56 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.56 | 19453300 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.08 | 16832597 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.30 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.30 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.30 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.57 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
9.87 | 16388313 |
MESH:D008546 |
Melanoma, Experimental |
|
Gallic Acid |
9.87 | 19577552 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.61 | 18411066 15451040 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.26 | 17268249 17109627 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.51 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.82 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.30 | 17098227 16815490 18497449 17261469 19165636 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.16 | 16801185 |
MESH:D008850 |
Microphthalmos |
|
ochratoxin A |
5.20 | 20036863 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.71 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
9.63 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
9.63 | 15867202 16118317 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
9.63 | 17049120 14749477 16490592 17935668 17164350 16267019 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Aluminum |
5.75 | 17086897 |
MESH:D020529 |
Multiple Sclerosis, Relapsing-Remitting |
|
Aluminum |
5.75 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.25 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
atorvastatin |
8.75 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
8.75 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.30 | 18186108 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.16 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
11.09 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
11.09 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
11.09 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
11.09 | 16317513 17188708 17015251 16525036 16456233 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.35 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.35 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.32 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.32 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.32 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
16.32 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.14 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
8.30 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
8.30 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.27 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.28 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
15.33 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
15.33 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Lindane |
15.33 | 16818664 12807735 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
15.33 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
15.33 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
15.33 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.24 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.24 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
8.85 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
8.85 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
8.31 | 17308104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.31 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.16 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.81 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
atorvastatin |
7.97 | 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.97 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
18.65 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
18.65 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
18.65 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
18.65 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
18.31 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
18.31 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
ochratoxin A |
18.31 | 20036863 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
18.31 | 19446573 10525206 18186108 11749123 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
18.31 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.29 | 15176712 8761367 16115947 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.30 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.27 | 8761367 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
8.80 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.80 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
12.63 | 8291058 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
12.63 | 16322990 |
MESH:D009503 |
Neutropenia |
|
Vitamin B 6 |
12.63 | 16322990 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
10.34 | 9802331 20557099 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
10.34 | 9802331 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
6.47 | 17217161 |
MESH:D009765 |
Obesity |
|
Fructose |
6.47 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.47 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
12.05 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
12.05 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
12.05 | 15612468 17119257 15576619 15727169 15913788 17178637 15935809 17479406 16737584 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.10 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.44 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
6.44 | 12665316 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
13.60 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
13.60 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
13.60 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.37 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
12.41 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
12.41 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
12.41 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
12.41 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
12.41 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.14 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
7.27 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
7.27 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
7.27 | 16965848 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
3.64 | 17698068 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.11 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.62 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
4.80 | 11026799 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.26 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.97 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.36 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
7.36 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
6.55 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
6.55 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
18.24 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
18.24 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
18.24 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
18.24 | 11118676 11896295 11399792 11222880 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
4.79 | 10903871 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.70 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.70 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
4.45 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
4.45 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
4.45 | 17079463 17308104 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
4.45 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.45 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
4.45 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
4.45 | 14688026 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
4.45 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
4.45 | 16731767 17636462 15767336 17804756 17675339 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
4.45 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
4.45 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
4.45 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
7.96 | 16919318 15861022 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
7.96 | 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.98 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.17 | 10548101 |
MESH:D011654 |
Pulmonary Edema |
|
Oleic Acid |
5.18 | 15090967 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
4.70 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.02 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
4.18 | 15728788 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.95 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.43 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.43 | 17058453 15827377 16317513 16314181 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.90 | 11700416 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oleic Acid |
7.90 | 18549715 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.25 | 18990726 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.11 | 16849425 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.92 | 16862918 |
MESH:D012559 |
Schizophrenia |
|
Copper |
3.84 | 16842975 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
3.84 | 16641680 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.25 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.54 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.54 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
10.54 | 9754883 |
MESH:D012640 |
Seizures |
|
Lindane |
10.54 | 12842176 15475178 7539098 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
6.93 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
6.93 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
6.93 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
10.84 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
10.84 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
10.84 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
10.84 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.47 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
9.47 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
4.90 | 16517039 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
4.87 | 16361298 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.42 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.31 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.71 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
5.49 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
5.49 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
5.49 | 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
5.49 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
5.49 | 17171786 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
9.08 | 18726076 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
9.08 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
9.08 | 17918041 9562338 11906479 16755016 17189318 9211565 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
16.59 | 16403987 16517955 |
MESH:D020521 |
Stroke |
|
Folic Acid |
16.59 | 16517955 |
MESH:D020521 |
Stroke |
|
Vitamin B 6 |
16.59 | 16517955 |
MESH:D020521 |
Stroke |
|
Vitamin E |
16.59 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.94 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.37 | 16045194 16684133 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.71 | 9754883 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.44 | 12837982 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.62 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.05 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.63 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.34 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.27 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.06 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.67 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
19.73 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
19.73 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
19.73 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
19.73 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
19.73 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
19.73 | 11723127 17306315 16712894 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
19.73 | 17572228 16712894 8653321 |
MESH:D014570 |
Urologic Diseases |
|
cypermethrin |
5.24 | 16487989 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.94 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.94 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
indole-3-carbinol |
12.95 | 16082211 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
12.95 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
12.95 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.38 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
12.72 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
12.72 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
12.72 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
9.68 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
9.68 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.81 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.96 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
8.93 | 14671159 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
8.93 | 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.70 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.62 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.81 | 17120751 |